Lova Sun, MD, MSCE
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
10 South Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
10 South Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
Education
AB (Ecology and Evolutionary Biology)
Princeton University , 2011.
MD (Medicine )
Perelman School of Medicine, University of Pennsylvania , 2015.
MSCE (Science and Clinical Epidemiology )
University of Pennsylvania , 2021.
Permanent linkAB (Ecology and Evolutionary Biology)
Princeton University , 2011.
MD (Medicine )
Perelman School of Medicine, University of Pennsylvania , 2015.
MSCE (Science and Clinical Epidemiology )
University of Pennsylvania , 2021.
Selected Publications
Lova Sun, Willdragon Wang, Keelia Clemens, Kyle Chang, Leslie Bucheit, Melina E. Marmarelis, Aditi Singh, Corey J. Langer, Roger B. Cohen & Charu Aggarwal : Long-term ctDNA reassessment in NSCLC immunotherapy responders. Communications Medicine Sept 2026.Millet YA, Spira AI, Baik CS, Hong MH, Shum E, Patel JD, Nguyen D, Janne PA, Piotrowska Z, Leighl NB, Matsumoto S, Sun L, Yang TY, Yoshida T, Nilsson MB, Heymach JV, Murray BW, Keats J, Lee S, Hsieh J, Zalutskaya A, Le X.: BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations. Mol Cancer Ther May 2026.
Lova Sun, Willdragon Wang, Kyle Chang, Leslie A. Bucheit, Keelia Clemens, Aditi P. Singh, Melina E. Marmarelis, Roger B. Cohen, Corey J. Langer, Charu Aggarwal: Long-term ctDNA reassessment (LTctDNA) in NSCLC immunotherapy responders. J Clin Oncol May 2026.
Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh: Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab. J Clin Oncol May 2026.
Adam Barsouk, Jonathan H. Sussman, Maxim Yaskolko, Lova Sun, Aditi P. Singh, Charu Aggarwal, Roger B. Cohen, Melina E. Marmarelis, Corey J. Langer: Performance status and tarlatamab outcomes in a large, multi-institution real-world database of 2L+ ES-SCLC. J Clin Oncol May 2026.
Rachel Jaber Chehayeb, Willdragon Wang, Lova Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Charu Aggarwal, Melina E. Marmarelis: Incidentally discovered lung cancer in explanted lungs at the time of lung transplantation: Management and outcomes. J Clin Oncol May 2026.
Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh: Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumab. J Clin Oncol May 2026.
Adam Barsouk, Maxim Yaskolko, Jonathan H. Sussman, Lova Sun, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Melina E. Marmarelis: Sotorasib vs adagrasib in the 2L+ setting: Outcomes in a large, multi-institutional, real-world database of KRAS-G12C mutated mNSCLC. J Clin Oncol May 2026.
Phurin Areesawangkit, Adam Barsouk, Maxim Yaskolko, Lucy Wang, Cole Friedes, Roger B. Cohen, Lova Sun, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Steven J. Feigenberg, Jeffrey D. Bradley, Nikhil Yegya-Raman, Michelle Iocolano, Christiana Davis, Corey J. Langer: Long-term survival outcomes of consolidative local ablative therapy after response to first-line systemic treatment in oligometastatic NSCLC. J Clin Oncol May 2026.
Teja Voruganti, Yi Lian, Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, David J. Cantor, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Melina E. Marmarelis, Aditi P. Singh, Corey J. Langer, Lova Sun, Charu Aggarwal: SPARK-Lung: A study of patterns and outcomes in young-onset lung cancer. J Clin Oncol May 2026.